Filing Details
- Accession Number:
- 0001628908-23-000178
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-20 08:01:03
- Reporting Period:
- 2023-11-15
- Accepted Time:
- 2023-11-20 08:01:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1628908 | Evolent Health Inc. | EVH | Services-Management Services (8741) | 320454912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1946147 | Joseph Daniel Mccarthy | C/O Evolent Health, Inc. 800 North Glebe Road, Suite 500 Arlington VA 22203 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2023-11-15 | 4,000 | $30.00 | 202,333 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-11-15 | 4,000 | $30.00 | 198,333 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2023-11-15 | 3,000 | $10.65 | 201,333 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-11-15 | 3,000 | $30.00 | 198,333 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Class A Common Option (right to buy) | Disposition | 2023-11-15 | 3,000 | $0.00 | 3,000 | $10.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-05-12 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2023.
- Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- The Class A Common Stock Options exercised vested on May 12, 2019.
Billionaire Hedge Funds
